Back to Trials
NCT00777712Recruiting

Mechanisms Underlying Impaired Diabetic Wound Healing

University of Pittsburgh

Start Date

9/1/2008

Completion Date

12/31/2030

Summary

The overall aim of this research is to utilize wound derived inflammatory cells from diabetic versus non diabetic human chronic wounds to understand mechanisms that are responsible for disregulated inflammation in individuals with diabetes. Biology of normal (peripheral blood derived cells) versus wound derived cells will also be studied.

Detailed Description

Specific aims: 1. To study biology of wound derived inflammatory cells and fluid from diabetic versus non diabetic wounds. 2. To characterize mechanisms that are responsible for dysregulated wound inflammatory cell function in individuals with diabetes. 3. To characterize differences in the biology of normal peripheral blood derived cells versus wound derived cells. The long-term goal of this study is to determine the molecular mechanisms underlying impaired wound healing in diabetics.

Eligibility Criteria

Age Range: 21 years to 80 years

Inclusion Criteria: * Ages 21-80 * Chronic Wound (present \>4 weeks) * Diabetic \& Non-diabetic * Adult surgical wounds Exclusion Criteria: * Inability to consent * Pregnant women * Therapeutically immunocompromised * Individuals defined in 45 CFR 46 Subparts B,C, and D, nor from any other population considered vulnerable 2.9

Interventions

OTHER

Blood draw

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Non-healing Wound

Locations

UPMC Montefiore

Pittsburgh, Pennsylvania 15219

United States

UPMC Presbyterian

Pittsburgh, Pennsylvania 15219

United States